Design, Synthesis, and Cellular Characterization of a New Class of IPMK Kinase Inhibitors

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Human inositol phosphate multikinase (IPMK) is crucial for synthesizing higher-order inositol phosphates.
• IPMK regulates gene expression and cell cycle control.
• Inositol phosphate signaling pathways are implicated in various cellular processes.

Purpose of the Study:

• To develop and characterize novel, potent inhibitors of IPMK.
• To investigate the effects of IPMK inhibition on glioblastoma cells.
• To explore the metabolic and transcriptomic consequences of IPMK inhibition.

Main Methods:

• Synthesis and optimization of IPMK inhibitors.
• Cellular proliferation assays using human U251-MG glioblastoma cells.
• Metabolic labeling and analysis of inositol phosphate levels (InsP5, InsP6, InsP7).
• Transcriptomic analysis to identify regulated genes.

Main Results:

• The first-generation inhibitor (UNC7437) reduced glioblastoma cell proliferation and altered inositol phosphate levels.
• UNC7437 impacted gene expression, particularly in cancer, EMT, inflammatory, and viral infection pathways.
• The optimized inhibitor (UNC9750) specifically inhibited InsP5 accumulation, the direct product of IPMK activity.

Conclusions:

• Novel IPMK inhibitors demonstrate potent anticancer activity.
• Chemical inhibition of IPMK leads to a distinct InsP5 metabolic signature.
• These findings provide new biological insights into inositol phosphate metabolism and signaling.